
Vitamin D Study Hints at Long COVID Relief
A major trial found vitamin D didn't stop COVID infections, but it may help reduce lingering symptoms weeks later. The discovery could offer hope to millions still struggling with long COVID.
Find uplifting stories about heroes, innovations, and solutions
12327 results for "long covid"

A major trial found vitamin D didn't stop COVID infections, but it may help reduce lingering symptoms weeks later. The discovery could offer hope to millions still struggling with long COVID.

A major clinical trial revealed that high-dose vitamin D didn't prevent severe COVID, but researchers discovered an unexpected clue that could help millions still battling long COVID symptoms.

A major study of 1,747 COVID patients found that vitamin D supplements may reduce the risk of developing long COVID by up to 4%. While it didn't help during acute infection, researchers discovered an encouraging link to fewer lingering symptoms months later.

A New Mexico court worker who couldn't drive or work after long COVID returned to normal life following eight weeks of hyperbaric oxygen therapy. Scientists are studying whether pressurized oxygen chambers could help millions suffering from the debilitating condition.

Scientists expected to find inflammation in long COVID brains, but scans revealed something different. The discovery could change how millions of patients get treated.

Scientists using quantum computers just identified hidden causes of long COVID that traditional AI missed, opening doors to new treatments. This breakthrough shows how quantum technology could revolutionize personalized medicine for everyone.

While many moved on from the pandemic, Dr. Michael Peluso launched a groundbreaking program to help millions still suffering from long COVID. His tissue bank has collected over 100,000 biospecimens and is helping scientists worldwide search for a cure.

Up to 18 million Americans live with Long COVID, but renewed attention from health officials signals hope for breakthrough treatments. A former CDC director draws parallels to how innovation transformed AIDS from fatal to treatable.

Researchers discovered a specific immune cell state that explains why Long COVID lingers in some patients and links directly to fatigue and breathing problems. The breakthrough could lead to personalized treatments for millions still suffering months after infection.

Millions with long COVID now have a free resource that lists 24 prescription medications and other treatment options they can discuss with doctors right now. Created by patients and clinicians, the guide aims to end the "nothing can be done yet" message many people hear.

A $1.35 million program is solving a major roadblock in Long COVID care by validating diagnostic tests that help doctors identify which treatments will work for which patients. The initiative brings researchers one step closer to turning promising science into real-world cures.

University of Virginia scientists have identified a cellular mechanism driving long COVID and found an existing drug that could help millions still suffering from the condition. Their breakthrough just won a national competition's first round, beating 63 other medical discoveries.

A digital tool combining activity tracking with real-time alerts helps people with long COVID avoid overexertion. While the six-month study showed promise, researchers discovered important insights for designing future health apps for chronic conditions.

Scientists discovered two blood molecules that can identify lung damage in COVID patients, potentially replacing invasive scans with a quick blood test. Nearly 1,000 hospitalized patients helped unlock this breakthrough that could speed up diagnosis and treatment.

A major new study of 434 children brings reassuring news for pregnant mothers: getting the COVID-19 mRNA vaccine during pregnancy shows no link to autism or developmental delays. The research tracked children up to 30 months old and found identical outcomes whether mothers received the vaccine or not.

A new pill can prevent you from catching COVID after exposure, cutting infection risk by two-thirds. It's the first medication proven to stop the virus before symptoms start.

Scientists at Stanford Medicine have developed a breakthrough nasal spray vaccine that protects against multiple respiratory threats at once, from COVID-19 and flu to bacterial infections and even allergies. In mice, the experimental vaccine provided months of broad protection by supercharging the lungs' natural defenses instead of targeting specific pathogens.

When Toronto locked down during COVID, a tiny forever chemical called TFA dropped dramatically in the atmosphere. Scientists say this discovery means we might actually be able to control these pollutants after all.

Retired professionals across Long Island are turning free time into community impact, with 500 AARP volunteers and 2,500 Northwell helpers leading a post-pandemic volunteer surge. From hospital pet therapy to lobbying in Albany, these experienced do-gooders prove that retirement is just the beginning.
Millions who lost their sense of smell during COVID now have real hope. Scientists are testing breakthrough treatments that could restore this life-changing sense.
Showing 20 of 12327